We bring high-value technologies designed to solve critical, analytical problems. We enable profound discoveries, optimize lab operations and ensure regulatory compliance. We help customers turn global industry challenges into the medicines that offer hope.
New OligoWorks Solid Phase Extraction (SPE) Kits for extraction and bioanalysis of oligonucleotides deliver advantages over liquid-liquid extraction (LLE) and other existing SPE kits and sample preparation methods. Read on to discover how.
The collaboration between Waters and AWS has enhanced the waters_connect System Monitoring tool, revolutionizing laboratory productivity. This cloud-based platform provides secure, compliant access to chromatography lab information, allowing users to coordinate work, address system errors, and make informed decisions from anywhere, anytime.
The integration of sustainability practices in analytical laboratories is not just a trend but a crucial shift towards a more responsible future. The ACQUITY QDa II Mass Detector shows how Waters enhances lab capabilities while also promoting sustainability.
Our goal is to create new value through the expanded global reach and combination of Waters and Wyatt technology. The delivery of these two pieces along with our deep scientific expertise, will support our customers to make life-changing therapies more accessible.
We believe we have created the most intuitively simple HPLC we have ever made. It is the first-ever system dedicated to the specific needs of the QC lab, and it will save our customers time, money, and stress.
An increased emphasis on new technology and innovation for pharmaceutical companies is contributing to the supply of more consistent quality and safer products for patients.
During a Waters-hosted roundtable discussion on the risk and cost associated with human errors in pharma quality control (QC) laboratories, key opinion leaders in the industry shared expert insights.
What does smart tech look like in an analytical lab today? Labs that are primed and ready to take advantage of future technological advances will get ahead of their competitors. How will a lab get there?
For contract organizations working in the pharmaceutical industry, operating at peak performance and capacity is a vital step towards delivering life-saving therapies.
Solving analytical challenges is at the core of our DNA and when it comes to oligonucleotide analysis, we’re at a point now where we can bring together the many advancements we’ve made across the analytical value stream into complete end-to-end workflows that truly deliver best-in-class analytical performance and productivity.
Healthcare Providers and medical device manufacturers alike are working diligently to ensure that their services and products are compliant with these new regulations in the medical device industry in the European Union (EU).
Waters has been progressing intact mass analyses for an equally long time. Development of the new waters_connect INTACT Mass app was a user-centric process.